JP2023544446A5 - - Google Patents
Info
- Publication number
- JP2023544446A5 JP2023544446A5 JP2023542830A JP2023542830A JP2023544446A5 JP 2023544446 A5 JP2023544446 A5 JP 2023544446A5 JP 2023542830 A JP2023542830 A JP 2023542830A JP 2023542830 A JP2023542830 A JP 2023542830A JP 2023544446 A5 JP2023544446 A5 JP 2023544446A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- group
- polycyclic
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063081089P | 2020-09-21 | 2020-09-21 | |
| US63/081,089 | 2020-09-21 | ||
| PCT/US2021/051375 WO2022061312A1 (en) | 2020-09-21 | 2021-09-21 | Sik inhibitors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544446A JP2023544446A (ja) | 2023-10-23 |
| JP2023544446A5 true JP2023544446A5 (cg-RX-API-DMAC7.html) | 2024-10-01 |
Family
ID=80775691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542830A Pending JP2023544446A (ja) | 2020-09-21 | 2021-09-21 | Ｓｉｋ阻害剤およびその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230265099A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4213851A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023544446A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117136061A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021343539A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3193194A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022061312A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4526307A1 (en) * | 2022-05-17 | 2025-03-26 | Soltego, Inc. | Pyrimidopyrimidone compounds and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104418860B (zh) * | 2013-08-20 | 2016-09-07 | 中国科学院广州生物医药与健康研究院 | 嘧啶并杂环类化合物及其药用组合物和应用 |
| WO2018009544A1 (en) * | 2016-07-05 | 2018-01-11 | The Broad Institute, Inc. | Bicyclic urea kinase inhibitors and uses thereof |
| US11241435B2 (en) * | 2016-09-16 | 2022-02-08 | The General Hospital Corporation | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis |
| AU2018226771B2 (en) * | 2017-02-28 | 2023-11-23 | Dana-Farber Cancer Institute, Inc. | Uses of pyrimidopyrimidinones as SIK inhibitors |
| CA3124574A1 (en) * | 2018-12-28 | 2020-07-02 | Spv Therapeutics Inc. | Cyclin-dependent kinase inhibitors |
| AU2021262482A1 (en) * | 2020-04-28 | 2023-01-05 | Iomx Therapeutics Ag | Bicyclic kinase inhibitors and uses thereof |
-
2021
- 2021-09-21 US US18/027,556 patent/US20230265099A1/en active Pending
- 2021-09-21 JP JP2023542830A patent/JP2023544446A/ja active Pending
- 2021-09-21 WO PCT/US2021/051375 patent/WO2022061312A1/en not_active Ceased
- 2021-09-21 CA CA3193194A patent/CA3193194A1/en active Pending
- 2021-09-21 CN CN202180078421.4A patent/CN117136061A/zh active Pending
- 2021-09-21 EP EP21870430.2A patent/EP4213851A4/en active Pending
- 2021-09-21 AU AU2021343539A patent/AU2021343539A1/en active Pending